Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: May 2012

Axesstel, Inc. (AXST) to Present at the 13th Annual B. Riley & Co. Investor Conference

Axesstel (OTCQB: AXST) is a leader in providing fixed wireless voice and broadband access solutions for the global telecommunications market. The company’s product portfolio includes fixed wireless phones, wire-line replacement terminals, and 3G and 4G broadband gateway devices. Headquartered in … Continue reading

Posted in B. Riley & Co. Conference | Leave a comment

Chembio Diagnostics, Inc. (CEMI) to Present at the 13th Annual B. Riley & Co. Investor Conference

Chembio Diagnostics (PINKSHEETS: CEMI) is a leading developer, manufacturer, licensor, and marketer of point-of-care diagnostic tests for infectious diseases. The company’s two FDA PMA-approved CLIA-waived rapid HIV tests are marketed in the United States by Alere North America, Inc., and … Continue reading

Posted in B. Riley & Co. Conference | Leave a comment

Electro Scientific Industries, Inc. (ESIO) to Present at the 13th Annual B. Riley & Co. Investor Conference

Electro Scientific Industries (NASDAQ: ESIO) specializes in advanced laser-based manufacturing solutions for the microtechnology industry. ESI’s systems facilitate precision structuring and testing of micron to submicron features in semiconductors, electronic devices, LEDs, and other components. ESI works with customers to … Continue reading

Posted in B. Riley & Co. Conference | Leave a comment

Cryoport, Inc. (CYRX) to Present at the 13th Annual B. Riley & Co. Investor Conference

Cryoport (OTCBB: CYRX) is a provider of leading edge cold chain logistics services through the combination of purpose-built proprietary technologies and total turnkey management of the process. The company’s Cryoport Express liquid nitrogen dry vapor shipper maintains a constant -150°C … Continue reading

Posted in B. Riley & Co. Conference | Leave a comment

Selectica, Inc. (SLTC) to Present at the 13th Annual B. Riley & Co. Investor Conference

Selectica (NASDAQ: SLTC) is a developer of innovative software – relied on by the world’s most successful companies – that accelerates sales cycles and streamlines contract processes. The company’s guided selling, sales configuration, and contract lifecycle management solutions support the … Continue reading

Posted in B. Riley & Co. Conference | Leave a comment

U.S. Home Systems, Inc. (USHS) to Present at the 13th Annual B. Riley & Co. Investor Conference

U.S. Home Systems (NASDAQ: USHS) is a provider of custom-quality specialty home improvement products. Included in the company’s product lines are kitchen cabinet re-facing products utilized in kitchen remodeling, bathroom tub liners and wall surround products used in bathroom remodeling, … Continue reading

Posted in B. Riley & Co. Conference | Leave a comment

BSQUARE Corp. (BSQR) to Present at the 13th Annual B. Riley & Co. Investor Conference

BSQUARE (NASDAQ: BSQR) is a worldwide leader in embedded solutions. The company applies experience and expertise on leading platforms to form new connections with customers, create new business models, and enable new methods of working and communicating. BSQUARE serves its … Continue reading

Posted in B. Riley & Co. Conference | Leave a comment

Market Leader (LEDR) to Present at the 13th Annual B. Riley & Co. Investor Conference

Market Leader (NASDAQ: LEDR) is a leading online provider of marketing and technology solutions for real estate professionals across the U.S. and Canada. Market Leader’s subscription-based real estate marketing software helps customers generate steady prospect streams and provides needed tools … Continue reading

Posted in B. Riley & Co. Conference | Leave a comment

Provectus Pharmaceuticals, Inc. (PVCT) to Present at the 13th Annual B. Riley & Co. Investor Conference

Provectus Pharmaceuticals (OTCBB: PVCT) is a development-stage oncology and dermatology biopharmaceutical company. PV-10, the company’s novel oncology drug, is designed to selectively target and destroy cancer cells without harming the surrounding healthy tissue. Provectus has received orphan drug designations from … Continue reading

Posted in B. Riley & Co. Conference | Leave a comment

Intevac, Inc. (IVAC) to Present at the 13th Annual B. Riley & Co. Investor Conference

Intevac (NASDAQ: IVAC) operates two business: Equipment, which is a leading designer, developer, and manufacturer of high-productivity vacuum process equipment solutions; and Intevac Photonics, a leading developer and manufacturer of high-sensitivity imaging products and vision systems, as well as materials … Continue reading

Posted in B. Riley & Co. Conference | Leave a comment